Lev Facher

Washington Correspondent

Lev Facher is a Washington Correspondent for STAT, reporting on the politics of health and life sciences. He has written extensively about the federal government's response to the opioid crisis, the pharmaceutical industry's influence on Capitol Hill, and federally funded biomedical research. Lev earned an economics degree from the University of Michigan, where he worked as managing editor of The Michigan Daily. You can reach him via email at lev.facher@statnews.com and by phone/WhatsApp/Signal at (510)-374-8880.

Politics

Lev Facher

Washington Correspondent

HHS will bring in fetal tissue experts for ‘listening session’

New ads push lawmakers to keep the drug pricing promises they made on the campaign trail

Rep. Peter Welch on drug prices, the potential for bipartisan action, and a ‘broken market’

Archived chat: The midterms are over. What’s next for health and medicine?

After successes at the ballot box, this drug pricing advocacy group is setting its sights on results

Bob Hugin concedes defeat in New Jersey — but doesn’t concede his pharma background played a role

Democrats took the House. Here’s what it means for health and medicine

In these eight midterms races, health and medicine are front and center

As Election Day neared, pharma spent more heavily on Democrats

Voters don’t like ‘Big Pharma.’ But they could soon elect a Senate that includes two pharma lobbyists and a CEO

Drug pricing goes local: State lawmakers around the country are pledging to take on pharma, too

Midterms in 30: Where things stand, one week before Election Day

Pharma’s ‘come-to-Jesus moment’: The industry braces for a Pelosi speakership and Democrats’ drug pricing agenda

Claire McCaskill’s boldest claims about the pharmaceutical industry, annotated

Despite modest gains, Trump basks in recognition for Washington’s response to the opioid crisis

Claire McCaskill is campaigning as pharma’s sworn enemy — and that’s the way she wants it

Eight midterm races putting pharma — and its influence — front and center

In public, lawmakers scold drug distributors. Come campaign season, they accept their cash willingly

Lev Facher

Washington Correspondent

Sign up for our Daily Recap newsletter